Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Commence Bio
company
About
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $400K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- May 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells. Commence aims to apply these methods in various inflammation-related disorders, including rheumatoid arthritis, by creating uniform cellular therapeutics with predictable behaviors.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$400K
Commence Bio has raised a total of
$400K
in funding over 2 rounds. Their latest funding was raised on
Oct 26, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2012 | Grant | $400K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Commence Bio is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
